US2006064786A1PendingUtilityA1

Isopentenyl transferase sequences and methods of use

Assignee: PIONEER HI BRED INTPriority: Sep 17, 2004Filed: Sep 16, 2005Published: Mar 23, 2006
Est. expirySep 17, 2024(expired)· nominal 20-yr term from priority
Y02A40/146C12N 9/1085C12N 15/8261C12Y 205/01027C12N 15/8216C12N 15/8295
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions for modulating plant development are provided. Polynucleotide sequences and amino acid sequences encoding isopentenyl transferase (IPT) polypeptides are provided. The sequences can be used in a variety of methods including modulating root development, modulating floral development, modulating leaf and/or shoot development, modulating senescence, modulating seed size and/or weight, and modulating tolerance of plants to abiotic stress. Polynucleotides comprising an IPT promoter are also provided. The promoter can be used to regulate expression of a sequence of interest. Transformed plants, plant cell, tissues, and seed are also provided.

Claims

exact text as granted — not AI-modified
1 . An isolated polypeptide comprising an amino acid sequence of SEQ ID NO: 2, 6, 9, 12, 15, 18, 23, 27, or 77.  
     
     
         2 . An isolated polypeptide comprising an amino acid sequence of SEQ ID NO: 41, 43, 46, 49, 52, 54, 57, 59, 61, 63, or 66.  
     
     
         3 . An isolated polypeptide comprising an amino acid sequence selected from the group consisting of: 
 (a) an amino acid sequence comprising at least 85% sequence identity to SEQ ID NO: 2, 6, 9, 12, 15, 18, 23, 27, 41, 43, 46, 49, 52, 54, 57, 59, 61, 63, 66, or 77, wherein said polypeptide has cytokinin synthesis activity;    (b) an amino acid sequence encoded by a polynucleotide that hybridizes under stringent conditions to the complement of a polynucleotide represented by SEQ ID NO: 1, 3, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 24, 26, 28, 40, 42, 44, 45, 47, 48, 50, 51, 53, 55, 56, 58, 60, 62, 64, 65, 69, 70, 71, 72, 73, 74, or 76, wherein said stringent conditions comprise hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37° C., and a wash in 0.1×SSC at 60° C. to 65° C., wherein said polypeptide retains cytokinin synthesis activity; and,    (d) an amino acid sequence comprising at least 50 consecutive amino acids of SEQ ID NO: 2, 6, 9, 12, 15, 18, 23, 27, 41, 43, 46, 49, 52, 54, 57, 59, 61, 63, 66, or 77, wherein said polypeptide retains cytokinin synthesis activity.    
     
     
         3 . An isolated polynucleotide comprising a nucleotide sequence of SEQ ID NO: 1, 3, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 24, 26, 28, or 76.  
     
     
         4 . An isolated polynucleotide comprising a nucleotide sequence of SEQ ID NO: 40, 42, 44, 45, 47, 48, 50, 51, 53, 55, 56, 58, 60, 62, 64, 65, 69, 70, 71, 72, 73, or 74.  
     
     
         5 . An isolated polynucleotide comprising a nucleotide sequence selected from the group consisting of: 
 (a) a nucleotide sequence encoding an amino acid sequence comprising SEQ ID NO: 2, 6, 9, 12, 15, 18, 23, 27, 41, 43, 46, 49, 52, 54, 57, 59, 61, 63, 66, or 77;    (b) a nucleotide sequence comprising at least 85% sequence identity to SEQ ID NO: 1, 3, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 24, 26, 28, 40, 42, 44, 45, 47, 48, 50, 51, 53, 55, 56, 58, 60, 62, 64, 65, 69, 70, 71, 72, 73, 74, or 76, wherein said polynucleotide encodes a polypeptide having cytokinin synthesis activity;    (c) a nucleotide sequence comprising at least 50 consecutive nucleotides of SEQ ID NO: 1, 3, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 24, 26, 28, 40, 42, 44, 45, 47, 48, 50, 51, 53, 55, 56, 58, 60, 62, 64, 65, 69, 70, 71, 72, 73, 74, or 76, wherein said polynucleotide encodes a polypeptide having cytokinin synthesis activity; and,    (d) a nucleotide sequence which represents a polynucleotide that hybridizes under stringent conditions to the complement of a polynucleotide represented by the nucleotide sequence of a), wherein said stringent conditions comprise hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37° C., and a wash in 0.1×SSC at 60° C. to 65° C.    
     
     
         6 . A transgenic plant comprising a polynucleotide operably linked to a promoter that drives expression in the plant, wherein said polynucleotide comprises a nucleotide sequence of  claim 5 , and wherein cytokinin level in said plant is modulated relative to a control plant.  
     
     
         7 . The plant of  claim 6 , wherein said cytokinin level is increased.  
     
     
         8 . The plant of  claim 6 , wherein said cytokinin level is decreased.  
     
     
         9 . The plant of  claim 6 , wherein said polynucleotide is operably linked to a a tissue-preferred promoter, a constitutive promoter, or an inducible promoter.  
     
     
         10 . The plant of  claim 9 , wherein said promoter is a root-preferred promoter, a leaf-preferred promoter, a shoot-preferred promoter, or an inflorescence-preferred promoter.  
     
     
         11 . The plant of  claim 6 , wherein said cytokinin level modulation affects floral development.  
     
     
         12 . The plant of  claim 6 , wherein said cytokinin level modulation affects root development.  
     
     
         13 . The plant of  claim 6 , wherein the plant has an altered shoot-to-root ratio.  
     
     
         14 . The plant of  claim 6 , wherein seed size or seed weight is increased.  
     
     
         15 . The plant of  claim 6 , wherein vigor or biomass yield of said plant is increased.  
     
     
         16 . The plant of  claim 6 , wherein the stress tolerance of said plant is increased.  
     
     
         17 . The plant of  claim 6 , wherein said plant is maize, and tip kernel abortion is reduced.  
     
     
         18 . The plant of  claim 6 , wherein said promoter is stress-insensitive and is expressed in a tissue of the developing seed or related maternal tissue at or about the time of anthesis.  
     
     
         19 . A transformed seed of the plant of  claim 6 .  
     
     
         20 . The plant of  claim 6 , wherein said plant is maize, wheat, rice, barley, sorghum, or rye.  
     
     
         21 . A plant that is genetically modified at a native genomic locus, said genomic locus comprising a polynucleotide of  claim 5 , wherein the cytokinin level of said plant is modulated.  
     
     
         22 . A method of modulating cytokinin level in a plant, comprising transforming said plant with a polynucleotide of  claim 5 , operably linked to a promoter.  
     
     
         23 . The method of  claim 22  wherein said modulation of cytokinin level affects root growth or the shoot-to-root ratio.  
     
     
         24 . The method of  claim 22  wherein said modulation of cytokinin level affects floral development.  
     
     
         25 . The method of  claim 22  wherein said modulation of cytokinin level increases seed size or seed weight.  
     
     
         26 . The method of  claim 22  wherein said modulation of cytokinin level increases plant stress tolerance.  
     
     
         27 . The method of  claim 22  wherein said modulation of cytokinin level affects vigor or biomass yield.  
     
     
         28 . The method of  claim 22  wherein said operably-linked promoter is a tissue-preferred and/or inducible promoter.  
     
     
         29 . The method of  claim 22  wherein said promoter is stress-insensitive and is expressed in a tissue of the developing seed or related maternal tissue at or about the time of anthesis.  
     
     
         30 . The method of  claim 22 , wherein senescence is delayed.  
     
     
         31 . The method of  claim 22  wherein sink strength of the seed of the plant is modulated.  
     
     
         32 . The method of  claim 31  wherein cytokinin level is increased in one or more of the embryo, the endosperm, and tissues proximal thereto.  
     
     
         33 . The method of  claim 32  wherein said proximal tissue comprises the pedicel.  
     
     
         34 . A method for modulating the rate or incidence of shoot regeneration in callus tissue, comprising expressing in said callus tissue a polynucleotide of  claim 5  operably linked to a heterologous promoter.  
     
     
         35 . The method of  claim 33 , wherein said promoter is inducible.  
     
     
         36 . An isolated polynucleotide comprising a nucleotide sequence of SEQ ID NO: 25 or 75 or a functional fragment or variant thereof.  
     
     
         37 . A DNA construct comprising a promoter operably linked to a nucleotide sequence of interest, wherein said promoter comprises the polynucleotide of  claim 36 .  
     
     
         38 . An expression vector comprising the DNA construct of  claim 37 .  
     
     
         39 . A plant comprising at least one DNA construct of  claim 37 .  
     
     
         40 . A method of regulating the expression of a nucleotide sequence of interest, said method comprising introducing into a plant a DNA construct of  claim 37 .  
     
     
         41 . The method of  claim 40  wherein said nucleotide sequence of interest is transcribed to form an RNA molecule which interferes with expression of a homologous native nucleotide sequence.  
     
     
         42 . A method of downregulating expression of ZmIPT1 or ZmIPT2 in a plant, comprising transforming said plant with a construct comprising a promoter operably linked to a polynucleotide which comprises a portion of the polynucleotide of  claim 36 , such that a hairpin molecule is formed which corresponds to the ZmIPT1 promoter or ZmIPT2 promoter.  
     
     
         43 . The method of  claim 42  wherein said promoter is tissue-preferred.

Join the waitlist — get patent alerts

Track US2006064786A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.